Figure S7 from Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer

This is a Quantitative Study study (also classified as: Cohort Study).

Key Points

Distinct mutation patterns are observed in long-term and short-term survivors of advanced high-grade serous tubo-ovarian cancer, indicating different biological underpinnings.
The study identifies specific mutations associated with patient outcomes, suggesting that certain mutations may contribute to resilience in long-term survivors.
A comparative transcriptome analysis is performed on matched cohorts of survivors, providing insights into the genetic factors influencing survival.
Understanding the mutation landscape could lead to targeted therapies aimed at improving the outcomes for patients with advanced high-grade serous tubo-ovarian cancer.

We only have this paper's title and publication details.

Analysis reveals distinct mutation profiles in advanced high-grade serous tubo-ovarian cancer patients, highlighting potential therapeutic targets.

Figure S7 shows the Mutation Landscape of TCGA LTS and STS Patients.

No takes yet. Share an insight, caveat, or question.

Marchenko et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share